Login to Your Account

Antisense Pharma Gets $39.5M For Antisense Glioma Product

By Cormac Sheridan

Wednesday, November 14, 2007
Antisense Pharma GmbH raised €27 million (US$39.5 million) in a third investment round funded solely by MIG AG, which also was the only investor in its €18 million funding round two years ago. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription